Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Banking Business Review
Return to: BBR Home | Suppliers

Wyeth Reduces Risk with Dyadem Software

Published 13 May 2010 | By Dyadem

Dyadem, the market leader in quality lifecycle management and risk lifecycle management solutions, has announced that Wyeth, a global leader in prescription pharmaceuticals and non-prescription consumer health care products, is using software from Dyadem to enhance and standardize its risk assessments.

2 Apr 2009

Dyadem's PHA-Pro, a software solution that identifies, measures and mitigates risk, enables Wyeth to set a new standard in safety for its pharmaceutical products. Wyeth's industry-leading pharmaceutical and health care products improve lives and deliver outstanding value to customers and shareholders by leading the world in innovation through pharmaceutical, biotech and vaccine technologies.

PHA-Pro is a software solution that delivers industry-standard process hazard analysis (PHA) capabilities for the process industries. The PHA methodology is an integral part of a pharmaceutical manufacturer's process safety management program and results in safer and more predictable production processes. Dyadem's PHA-Pro helps manage risk lifecycle management processes, and was built to reflect the risk mitigation initiatives and operating environments of the various process industries. This is essential to optimising work time, minimising work stoppages, and reducing the potential for undesirable events, while improving the safety and quality of a given product for consumers.

With PHA-Pro being used across their global organization, Wyeth has integrated the knowledge and expertise of all departments into their PHA studies and provided the environmental health and Safety department visibility into the overall business process, making everyone at the company more aware of their global business and safety strategy. "We needed a systematic, methodical way to document our PHA studies," said Steven Meszaros, corporate director, EHS (Environmental Health and Safety), Wyeth. "With Dyadem's PHA-Pro, Wyeth has been able to establish a community of users and a standardized approach to our PHA studies. It has allowed us to create a benchmark for safety and quality for our company, which will ultimately benefit our customers."

Having used PHA-Pro for many years, Wyeth has been able to continuously improve their risk management program. The easy configuration of templates, along with the application's industry-specific libraries and report-generating features have allowed Wyeth to focus on their business process and overall business strategy, instead of worrying about the consistency of their PHA studies. Since implementing PHA-Pro, Wyeth has been able to establish a best-practice platform which has proven to management the value of a consistent hazard review process across the network.

"Wyeth's commitment to safety and visibility for all departments are some of the reasons it has remained a leader in the pharmaceutical industry," said Kevin North, President and CEO of Dyadem. "Pharmaceutical companies have traditionally had challenges ensuring consistency and accuracy in their risk assessments, but with our risk lifecycle management solutions, we have given the industry a chance to address this. Wyeth shows how important it is to standardise risk mitigation initiatives, and provide an avenue for input from all areas of a business. Through their commitment to product safety, Wyeth proves how easy it is to create safe, quality products and still be on the leading edge of innovation."